中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

铁调素和IL-6在非酒精性脂肪性肝病大鼠模型肝脏炎症进程中的表达水平及相关性分析

赵睿 李娟 王亮 孔银 丁洁 王娟霞 李光明 张岭漪

引用本文:
Citation:

铁调素和IL-6在非酒精性脂肪性肝病大鼠模型肝脏炎症进程中的表达水平及相关性分析

DOI: 10.3969/j.issn.1001-5256.2017.09.030
基金项目: 

2014年甘肃省自然科学基金项目(145RJZA147); 中央高校基本科研业务费专项资金(223000-861240); 

详细信息
  • 中图分类号: R-332;R575.5

Expression of hepcidin and interleukin-6 and their correlation in liver inflammation process in a rat model of nonalcoholic fatty liver disease

Research funding: 

 

  • 摘要:

    目的利用非酒精性脂肪性肝病(NAFLD)大鼠模型观察铁调素(Hepc)、IL-6在肝脏炎症进程中表达水平的变化。方法NAFLD肝组织标本均来自本课题组前期利用高脂乳剂灌胃法成功构建的大鼠NAFLD模型(M组)及同期生理盐水灌胃替代构建的正常大鼠对照组(C组)。Hepc、IL-6单克隆抗体应用免疫组织化学法分别检测4、8、12周M组(M4、M8、M12)和12周C组大鼠肝组织中Hepc、IL-6的表达水平,同期评估各组肝脂肪炎症程度积分。检测2组大鼠肝组织Hepc和IL-6的表达水平,并计算肝组织NAS积分。多组间比较采用单因素方差分析,组间进一步两两比较采用LSD-t相关法。相关性分析均采用Pearson相关法。结果随试验周期延长,Hepc和IL-6在M4组、M8组、M12组表达水平呈逐渐升高的趋势,且与C12组相比差异均有统计学意义(Hepc:0.372±0.216、1.213±0.193、2.390±0.192 vs 0.166±...

     

  • [1]DATZ C, FELDER TK, NIEDERSEER D, et al.Iron homeostasis in the metabolic syndrome[J].Eur J Clin Investig, 2013, 43 (2) :215-224.
    [2]DONGIOVANNI P, FRACANZANI AL, FARGION S, et.al.Iron in fatty liver and in the metabolic syndrome:a promising therapeutic target[J].Hepatol, 2011, 55 (2) :920-932.
    [3]ANTONELLO P.Hepcidin in human iron disorders:therapeutic implications[J].Hepatology, 2011, 54 (2) :173-181.
    [4] WANG J, PANTOPOULOS K.Regulation of cellular iron metabolism[J].Biochem, 2011, 434 (2) :365-381.
    [5]DING J, WANG L, LI J, et al.Reliability of metabolic and pathologic parameters in the high fat diet-induced nonalcoholic fatty liver disease rat model established by gastric perfusion[J].J Clin Hepatol, 2012, 7 (2) :531-534. (in Chinese) 丁洁, 王亮, 李娟, 等.高脂乳剂灌胃构建大鼠非酒精性脂肪肝病模型可靠性的再研究[J].临床肝胆病杂志, 2012, 7 (2) :531-534.
    [6]FU Q, LI P, XIONG F, et al.Dicussion of enhancement of normal SP immunohistochemical staining[J].J Hubei Univ Chin Med, 2013, 15 (5) :24-26. (in Chinese) 富青, 李萍, 熊凡, 等.改良常规SP免疫组化染色法的探讨[J].湖北中医药大学学报, 2013, 15 (5) :24-26.
    [7] Group of Fatty Liver and Alcoholic Liver Diseases, Society of Hepatology, Chinese Medical Association.Guidelines for management of non-alcoholic fatty liver disease[J].J Clin Hepatol, 2010, 26 (2) :120-124. (in Chinese) 中华医学会肝病学分会.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志, 2010, 26 (2) :120-124.
    [8]AIGNER E, WEISS G, DATZ C.Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver[J].World J Hepatol, 2015, 7 (2) :177-188.
    [9]WANG FG, LIANG WF, XI JJ.Establishment and applications of non-alcoholic steatohepatitis animal models[J].Chin J Clin Pharmacol Ther, 2015, 20 (7) :835-840. (in Chinese) 王福根, 梁伟峰, 席建军, 等.非酒精性脂肪性肝炎动物模型的建立与应用[J].中国临床药理学与治疗学, 2015, 20 (7) :835-840.
    [10] BOQA S, ALKIN H, ALKIN C, et.al.The relationship of serum hemojuvelin and hepcidin levels with iron overload in nonalcoholic fatty liver disease[J].Gastrointestin Liver Dis, 2015, 24 (3) :293-300.
    [11] RAVASI G, PELUCCHI S, TROMBINI P, et al.Hepcidin expression in iron overload diseases in variably moclulated by circulating[J].PLos One, 2012, 7 (5) :e36425.
    [12] GANZ T.Hepcidin and iron regulation, 10 years later[J].Blood, 2011, 117 (17) :4425-4433.
    [13] GANZ T.Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation[J].Blood, 2003, 102 (3) :783-788.
  • 加载中
计量
  • 文章访问数:  1994
  • HTML全文浏览量:  58
  • PDF下载量:  439
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-06-10
  • 出版日期:  2017-09-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回